PROTAC
PROTAC(蛋白降解靶向嵌合体)
The PROTAC molecule itself contains three distinct portions: a ligand for binding to the target protein, a ligand for binding to an E3 ligase, and a linker joining these two ligands.
PROTACs (proteolysis-targeting chimaeras) are bifunctional molecules that bring a target protein into spatial proximity with an E3 ubiquitin ligase to trigger target ubiquitination and subsequent proteasomal degradation. Effective redirection of ligase poly-ubiquitination activity toward a new substrate protein requires formation of a ligase:PROTAC:target ternary complex, an intermediate species that is crucial to the cellular activity of degrader molecules. A characteristic feature of PROTACs mode of action is their sub-stoichiometric catalytic activity that alleviates the requirement for target engagement and occupancy of traditional inhibitors. New PROTAC molecules designed guided by the crystal structure show exquisite selectivity for inducing cellular depletion of Brd4 over its BET family members Brd2 and Brd3.
PROTAC 相关产品(146)
- GC50729VH 101 phenol-alkylC6-amineCAS: 2564467-16-7纯度: >95.00%
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkylC6 linker with terminal amine ready for conjugation to a target protein ligand
- GC50730VH 032 amide-alkylC8-acidCAS: 2172819-77-9纯度: >95.00%
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus alkylC8 linker with terminal carboxylic acid ready for conjugation to a target protein ligand
- GC50731VH 032 amide-PEG4-amineCAS: 2446474-04-8纯度: >95.00%
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG linker ready for conjugation to a target protein ligand
- GC50737A 410099.1 amide-PEG4-amineCAS: 2446474-10-6纯度: >95.00%
Functionalized IAP ligand for PROTAC® research and development; incorporates an IAP ligand plus an amide-PEG4 linker with terminal amine ready for conjugation to a target protein ligand
- GC50739A 410099.1 amide-PEG5-amineCAS: 2446474-11-7纯度: >95.00%
Functionalized IAP ligand for PROTAC® research and development; incorporates an IAP ligand plus an amide-PEG5 linker with terminal amine ready for conjugation to a target protein ligand
- GC50745TBK1 PROTAC® 3iCAS: 2052306-13-3纯度: >98.00%
Potent TANK-binding kinase 1 (TBK1) Degrader (DC50 = 12 nM, Dmax = 96%)
- GC50755dTAGV-1-NEGCAS: 2451573-87-6纯度: >99.50%
dTAGV-1-NEG 是一种非对映异构体,是 dTAGV-1 的异双功能阴性对照。 dTAGV-1 是一种 FKBP12F36V 选择性降解剂。
- GC60009(S,R,S)-AHPC-PEG5-COOHCAS: 2172820-14-1纯度: >95.00%
(S,R,S)-AHPC-PEG5-COOH (VH032-PEG5-COOH) 是一种合成的 E3 连接酶配体-linker 偶联物,包含基于 (S,R,S)-AHPC 的 VHL 配体和 5 个单元 PEG linker。
- GC60307PROTAC RIPK degrader-2CAS: 1801547-16-9纯度: >99.00%
PROTAC RIPK degrader-2 是一种非肽性PROTAC,它以丝氨酸苏氨酸激酶 RIPK2 为靶点,对 RIPK2 的降解具有高度选择性。
- GC61200Pomalidomide-PEG1-C2-N3CAS: 2271036-44-1纯度: >99.50%
Pomalidomide-PEG1-C2-N3是一种合成的E3连接酶配体-linker偶联物,包含基于Pomalidomide的cereblon配体和1个单元PEG的linker。Pomalidomide-PEG1-C2-N3可通过PROTAC技术合成选择性的CDK6降解剂CP-10。CP-10诱导CDK6降解,DC50为2.1nM。
- GC61212PROTAC BRD4 Degrader-5CAS: 2409538-70-9纯度: >99.50%
PROTACBRD4Degrader-5是一种基于PROTAC的BRD4降解剂,可有效降解HER2阳性和阴性乳腺癌细胞系中的BRD4。
- GC61215PROTAC RIPK degrader-6CAS: 2089205-64-9纯度: >99.00%
PROTACRIPKdegrader-6(example1)是一种PROTAC类的有效RIPK降解剂。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC50729 | VH 101 phenol-alkylC6-amine | 2564467-16-7 | >95.00% | |
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkylC6 linker with terminal amine ready for conjugation to a target protein ligand | ||||
| GC50730 | VH 032 amide-alkylC8-acid | 2172819-77-9 | >95.00% | |
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus alkylC8 linker with terminal carboxylic acid ready for conjugation to a target protein ligand | ||||
| GC50731 | VH 032 amide-PEG4-amine | 2446474-04-8 | >95.00% | |
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG linker ready for conjugation to a target protein ligand | ||||
| GC50736 | dBRD9-A | 2170679-42-0 | >98.00% | |
Potent BRD9 degrader | ||||
| GC50737 | A 410099.1 amide-PEG4-amine | 2446474-10-6 | >95.00% | |
Functionalized IAP ligand for PROTAC® research and development; incorporates an IAP ligand plus an amide-PEG4 linker with terminal amine ready for conjugation to a target protein ligand | ||||
| GC50739 | A 410099.1 amide-PEG5-amine | 2446474-11-7 | >95.00% | |
Functionalized IAP ligand for PROTAC® research and development; incorporates an IAP ligand plus an amide-PEG5 linker with terminal amine ready for conjugation to a target protein ligand | ||||
| GC50740 | NR 7h | 2550399-06-7 | >97.00% | |
Potent and selective p38α and p38β degrader (DC50 < 50 nM) | ||||
| GC50744 | ARCC 4 negative control | 2156588-26-8 | >98.00% | |
Negative control for ARCC 4 | ||||
| GC50745 | TBK1 PROTAC® 3i | 2052306-13-3 | >98.00% | |
Potent TANK-binding kinase 1 (TBK1) Degrader (DC50 = 12 nM, Dmax = 96%) | ||||
| GC50746 | TBK1 control PROTAC® 4 | 2052306-31-5 | >98.00% | |
Negative control for TBK1 PROTAC? 3i | ||||
| GC50748 | SJF 1528 | 2230821-38-0 | >98.00% | |
Potent EGFR Degrader (DC50 values are 39 | ||||
| GC50749 | DD 03-171 | 2366132-45-6 | >98.00% | |
Potent and selective BTK Degrader (IC50 = 5 | ||||
| GC50752 | SJF 1521 | 2230821-40-4 | >98.00% | |
Selective EGFR Degrader | ||||
| GC50753 | SJF 8240 | 2230821-68-6 | >98.00% | |
c-MET degrader | ||||
| GC50754 | dTAG-13-NEG | 2451573-90-1 | >98.00% | |
Negative control for dTAG-13 | ||||
| GC50755 | dTAGV-1-NEG | 2451573-87-6 | >99.50% | |
dTAGV-1-NEG 是一种非对映异构体,是 dTAGV-1 的异双功能阴性对照。 dTAGV-1 是一种 FKBP12F36V 选择性降解剂。 | ||||
| GC50756 | dTAGV-1 TFA | 2624313-15-9 | >98.00% | |
Degrader targeting mutant FKBP12F36V fusion proteins | ||||
| GC50757 | dTAGV-1 hydrochloride | 2624313-16-0 | >98.00% | |
Hydrochloride salt of dTAGV-1 | ||||
| GC60009 | (S,R,S)-AHPC-PEG5-COOH | 2172820-14-1 | >95.00% | |
(S,R,S)-AHPC-PEG5-COOH (VH032-PEG5-COOH) 是一种合成的 E3 连接酶配体-linker 偶联物,包含基于 (S,R,S)-AHPC 的 VHL 配体和 5 个单元 PEG linker。 | ||||
| GC60307 | PROTAC RIPK degrader-2 | 1801547-16-9 | >99.00% | |
PROTAC RIPK degrader-2 是一种非肽性PROTAC,它以丝氨酸苏氨酸激酶 RIPK2 为靶点,对 RIPK2 的降解具有高度选择性。 | ||||
| GC60594 | ARCC-4 | 1973403-00-7 | >99.50% | |
ARCC-4是基于PROTAC技术的,纳摩尔级的雄激素受体(AR)降解剂,其D50值为5 nM。ARCC-4是一种基于enzalutamide的vonHippel-Lindau(VHL)招募的ARPROTAC。ARCC-4能有效降解与抗雄激素研究相关的AR突变。 | ||||
| GC61200 | Pomalidomide-PEG1-C2-N3 | 2271036-44-1 | >99.50% | |
Pomalidomide-PEG1-C2-N3是一种合成的E3连接酶配体-linker偶联物,包含基于Pomalidomide的cereblon配体和1个单元PEG的linker。Pomalidomide-PEG1-C2-N3可通过PROTAC技术合成选择性的CDK6降解剂CP-10。CP-10诱导CDK6降解,DC50为2.1nM。 | ||||
| GC61212 | PROTAC BRD4 Degrader-5 | 2409538-70-9 | >99.50% | |
PROTACBRD4Degrader-5是一种基于PROTAC的BRD4降解剂,可有效降解HER2阳性和阴性乳腺癌细胞系中的BRD4。 | ||||
| GC61215 | PROTAC RIPK degrader-6 | 2089205-64-9 | >99.00% | |
PROTACRIPKdegrader-6(example1)是一种PROTAC类的有效RIPK降解剂。 | ||||
